# EDGAR Filing Document

**Accession Number:** 0000708818
**File Stem:** 0000950170-23-001988
**Filing Date:** 2023-2
**Character Count:** 5555
**Document Hash:** 94f7287f5ef484fb9c330ebca90a018d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000950170-23-001988.hdr.sgml**: 20230207

**ACCESSION NUMBER**: 0000950170-23-001988

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20230202

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230207

**DATE AS OF CHANGE**: 20230207

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NEXTGEN HEALTHCARE, INC.
- **CENTRAL INDEX KEY:** 0000708818
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
- **IRS NUMBER:** 952888568
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-12537
- **FILM NUMBER:** 23595215

**BUSINESS ADDRESS:**
- **STREET 1:** 18111 VON KARMAN AVENUE
- **STREET 2:** SUITE 600
- **CITY:** IRVINE
- **STATE:** CA
- **ZIP:** 92612
- **BUSINESS PHONE:** 949-255-2600

**MAIL ADDRESS:**
- **STREET 1:** 18111 VON KARMAN AVENUE
- **STREET 2:** SUITE 600
- **CITY:** IRVINE
- **STATE:** CA
- **ZIP:** 92612

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** QUALITY SYSTEMS, INC
- **DATE OF NAME CHANGE:** 20180823

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NEXTGEN HEALTHCARE, INC
- **DATE OF NAME CHANGE:** 20180823

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** QUALITY SYSTEMS, INC
- **DATE OF NAME CHANGE:** 20100804

?xml version="1.0" encoding="ASCII"? 8-K

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549** 

------

**FORM** 8-K

------

**CURRENT REPORT** 

**Pursuant to Section 13 or 15(d)**

 **of the Securities Exchange Act of 1934** 

**Date of Report** 

**(Date of earliest event reported):**

February 2, 2023

------

NEXTGEN HEALTHCARE, INC.

 **(Exact name of Registrant as Specified in Its Charter)** 

---

| | | |
|:---|:---|:---|
| Delaware | 001-12537 | 95-2888568 |
| **(State or Other Jurisdiction**<br>**of Incorporation)** | **(Commission**<br> **File Number)** | **(IRS Employer**<br>**Identification No.)** |
| **Not Applicable(1)** |  | **Not Applicable(1)** |
| **(Address of Principal Executive Offices)** |  | **(Zip Code)** |

---

**Registrant's Telephone Number, Including Area Code: Not Applicable**<sup>(1)</sup>

**Not Applicable**

**(Former Name or Former Address, if Changed Since Last Report)** 

------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading**<br>**Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock (Par Value $0.01) | NXGN | NASDAQ Global Select Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)NextGen Healthcare, Inc. is a remote-first company and no longer maintains its principal executive office. For purposes of compliance with applicable requirements of the Securities Act of 1933, as amended, and Securities Exchange Act of 1934, as amended, stockholder communications required to be sent to our principal executive offices should be directed to the email address set forth in our proxy materials and/or identified on our investor relations website.

------

**Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**

On February 2, 2023, David A. Metcalfe, Executive Vice President & Chief Technology Officer of NextGen Healthcare, Inc. (the "<u>Company</u>"), notified the Company of his resignation from the Company effective February 17, 2023.

**Item 9.01 Financial Statements and Exhibits.**

(d) Exhibits

---

| | |
|:---|:---|
| Exhibit No. | Description |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| Date: February 7, 2023 | NEXTGEN HEALTHCARE, INC. | NEXTGEN HEALTHCARE, INC. |
|  | By: | /s/ Jeffrey D. Linton |
|  |  | Jeffrey D. Linton |
|  |  | Executive Vice President, General Counsel & Secretary |

---

------